Davis R Ingram

7PUBLICATIONS
86CO-AUTHORS
Molecular targetsSolid tumoursPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Jan 15, 2026
Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma.

David S Moura, Jesus Lopez-Marti, Hussein Tawbi

|Oct 03, 2025
EWS::WT1 Isoform-Dependent Regulation of Neogenes in Desmoplastic Small Round Cell Tumors.

Danh D Truong, Justin W Magrath, Kevin Murgas

|Jan 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.

Sandra L Grimm, Menuka Karki, Kyle A Blum

|Apr 01, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.

Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas

|Jan 05, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.

Tuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui

Pageof 2

Frequent Collaborators

6 joint publications

Alexander Lazar

4 joint publications

Wei-Lien Wang

4 joint publications

Khalida Wani

3 joint publications

Rossana Lazcano